Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 22.84B | 19.75B | 18.51B | 19.50B | 26.71B |
Gross Profit | 9.02B | 7.67B | 6.95B | 7.29B | 7.10B |
EBITDA | 4.59B | 3.48B | 2.91B | 3.14B | 2.83B |
Net Income | 2.41B | 1.74B | 1.32B | 1.53B | 1.24B |
Balance Sheet | |||||
Total Assets | 23.86B | 23.79B | 22.14B | 23.13B | 22.81B |
Cash, Cash Equivalents and Short-Term Investments | 5.51B | 5.02B | 3.81B | 4.72B | 5.72B |
Total Debt | 3.60B | 4.02B | 4.87B | 5.85B | 6.59B |
Total Liabilities | 11.49B | 13.10B | 12.99B | 14.91B | 15.82B |
Stockholders Equity | 12.36B | 10.58B | 9.05B | 8.13B | 6.90B |
Cash Flow | |||||
Free Cash Flow | 1.51B | 2.49B | 267.98M | -37.23M | 3.18B |
Operating Cash Flow | 2.20B | 3.14B | 1.04B | 600.13M | 3.86B |
Investing Cash Flow | -692.74M | -581.47M | -446.32M | -589.68M | -613.60M |
Financing Cash Flow | -1.07B | -1.31B | -1.43B | -1.02B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥13.43B | 5.61 | 4.19% | 14.44% | 28.75% | ||
81 Outperform | ¥2.53B | 6.52 | 2.42% | 5.06% | 245.18% | ||
80 Outperform | ¥23.12B | 10.34 | 2.75% | 15.39% | 27.17% | ||
63 Neutral | ¥9.20B | 25.29 | 1.96% | -0.66% | -11.08% | ||
55 Neutral | ¥3.04B | 11.98 | 3.65% | -12.84% | -57.15% | ||
47 Neutral | ¥17.56B | 98.19 | 4.11% | -6.24% | -146.29% | ||
44 Neutral | C$923.76M | -8.68 | -0.23% | 2.69% | 24.53% | -41.45% |